Semble, a London-based health tech firm, has successfully raised £11.6 million in its Series B funding round.
- The capital injection is aimed at expanding Semble’s innovative IT solutions overseas, addressing outdated systems in healthcare.
- The British Medical Association highlights inefficiencies in current healthcare IT systems, leading to millions of lost working hours.
- Semble’s platform seeks to provide automated workflows and secure data exchanges, integrating seamlessly with third-party systems.
- CEO Christoph Lippuner emphasises the mission to enhance healthcare delivery through advanced technological integrations.
In a significant stride forward, Semble, a pioneering health technology startup based in London, has secured £11.6 million in a Series B funding round. This substantial financial backing, led by Mercia Ventures with contributions from Octopus Ventures, Smedvig Ventures, and Triple Point, marks a key phase in the company’s ambitious expansion plans aimed at revolutionising the healthcare IT landscape.
The funds will bolster Semble’s efforts in providing modernised IT solutions that cater to the urgent need for replacing antiquated technology frequently utilised by medical providers. A recent estimate by the British Medical Association indicates that healthcare professionals in England are hindered by inefficient IT setups, losing over 13 million working hours annually as a result. Semble’s innovative platform is designed to counter these inefficiencies through enhanced automation of routine tasks, facilitating more secure patient data management, and ensuring compatibility with additional systems.
Christoph Lippuner, the CEO and co-founder of Semble, has highlighted the company’s core mission to amplify the effectiveness of healthcare professionals by alleviating their reliance on outdated systems which detract from patient-focused care. According to Lippuner, significant investment in workflow automation and integration is pivotal in positioning Semble as a leader in AI-driven healthcare solutions, thus fostering a cohesive and interconnected medical ecosystem.
Since its inception in 2018, Semble has progressed swiftly under Lippuner and Mikael Landau, who previously established and sold the startup Orogo. This latest funding achievement underscores a continued growth trajectory spurred by their profound understanding of healthcare sector challenges and the company’s proven capability to address these issues. Semble’s prior funding rounds include an $8.3 million Series A concluded in September 2021, bringing their total funding to $27 million.
Alex Gwyther of Mercia Ventures has noted the critical juncture at which the healthcare market finds itself, with rapid growth clashing against the backdrop of outdated legacy systems. Gwyther expressed confidence in Semble’s potential to harness this market opportunity, given its founders’ deep insights and the urgent demand for modernisation within the sector.
Semble’s strategic funding round positions it well to lead the transition towards efficient, technologically advanced healthcare systems.
